Found the link to the full report, you can download the PDF for free. Just started reading it and already found this very interesting from page 3. https://nap.nationalacademies.org/catalog/27766/cannabis-policy-impacts-public-health-and-health-equity Also, Yasmin Hurd, Mt Sinai is one of the co-chairs. Recall reading an old post by someone mentioning her and a clinical trial that this company is involved with her? Have to finish reading the report. See you in a few days, lol.
The Food
and Drug Administration could approve medical use of a botanical cannabis
product by prescription, through its drug approval process, but it is
unclear whether that will happen. The impact on state cannabis programs
remains unclear, as does the impact on public health.
STUDY CHARGE AND APPROACH
The need for a comprehensive public health review of cannabis policy
prompted the Centers for Disease Control and Prevention (CDC) and the
National Institutes of Health to commission the National Academies of
Sciences, Engineering, and Medicine to convene an ad hoc committee charged
with describing cannabis and cannabinoid availability in the United States;